home / stock / asmb / asmb quote
Last: | $15.13 |
---|---|
Change Percent: | -1.43% |
Open: | $15.205 |
Close: | $15.13 |
High: | $15.45 |
Low: | $14.82 |
Volume: | 6,677 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$15.13 | $15.205 | $15.13 | $15.45 | $14.82 | 6,677 | 07-19-2024 |
$14.99 | $15.41 | $14.99 | $15.41 | $14.655 | 5,080 | 07-18-2024 |
$15.12 | $14.75 | $15.12 | $15.1877 | $14.75 | 2,977 | 07-17-2024 |
$15.3 | $15.67 | $15.3 | $15.67 | $15.1 | 13,213 | 07-16-2024 |
$15.37 | $14.69 | $15.37 | $15.7 | $14.1755 | 13,069 | 07-15-2024 |
$14.8 | $14.44 | $14.8 | $14.96 | $14.048 | 15,908 | 07-12-2024 |
$14.3 | $13.95 | $14.3 | $14.3001 | $13.7151 | 18,417 | 07-11-2024 |
$13.83 | $13.65 | $13.83 | $14.4164 | $13.6 | 20,823 | 07-10-2024 |
$13.77 | $14.16 | $13.77 | $14.16 | $13.66 | 6,873 | 07-09-2024 |
$13.85 | $13.42 | $13.85 | $13.95 | $13.1 | 19,465 | 07-08-2024 |
$13.21 | $12.4 | $13.21 | $13.24 | $12.4 | 16,663 | 07-05-2024 |
$12.15 | $12.6 | $12.15 | $12.6 | $11.52 | 38,183 | 07-04-2024 |
$12.15 | $12.6 | $12.15 | $12.6 | $11.52 | 38,183 | 07-03-2024 |
$13.35 | $13.19 | $13.35 | $13.7 | $13.09 | 12,976 | 07-02-2024 |
$13.24 | $13.55 | $13.24 | $13.7115 | $12.8 | 33,328 | 07-01-2024 |
$13.72 | $14.75 | $13.72 | $14.75 | $13.23 | 35,095 | 06-28-2024 |
$14.6 | $14.45 | $14.6 | $14.75 | $14.4 | 6,769 | 06-27-2024 |
$14.3 | $15.21 | $14.3 | $15.315 | $14.11 | 28,012 | 06-26-2024 |
$15.4 | $15.6 | $15.4 | $16.1379 | $15.2 | 11,040 | 06-25-2024 |
$15.7 | $15.43 | $15.7 | $15.74 | $15.4 | 14,185 | 06-24-2024 |
News, Short Squeeze, Breakout and More Instantly...
Assembly Biosciences Inc. Company Name:
ASMB Stock Symbol:
NASDAQ Market:
Assembly Biosciences Inc. Website:
2024-07-16 14:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
– Data from both ABI-5366 and ABI-1179, novel long-acting helicase-primase inhibitor candidates for recurrent genital herpes, to be presented – – Poster presentation highlights key preclinical data from ABI-5366 supporting its entry into ongoing Phase 1a/b clinical ...
SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced that the first participant has been dosed in the Phase 1b trial of ABI-4334, a nex...